Likely due to cross-reactivity of skeletal and cardiac troponin isoforms in commercial immunoassays, it has been recently shown that skeletal myopathies can also result in an apparent elevation of cTnT concentration [42]. Here, TNNT2 is linked to skeletal muscle disorder.